Autopsy report · NCT05284214

Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors

“Study did not commence.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Partner Therapeutics, Inc.

Sponsor type

Industry

Conditions

Solid Tumor; Solid Tumor, Adult

Interventions

Sargramostim; Ipilimumab-containing therapy

Participants

0

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.